TY - JOUR
T1 - Uptake of PHMB in a bacterial nanocellulose-based wound dressing
T2 - A feasible clinical procedure
AU - de Mattos, Ives Bernardelli
AU - Holzer, Judith C.J.
AU - Tuca, Alexandru Cristian
AU - Groeber-Becker, Florian
AU - Funk, Martin
AU - Popp, Daniel
AU - Mautner, Selma
AU - Birngruber, Thomas
AU - Kamolz, Lars Peter
N1 - Publisher Copyright:
© 2018
PY - 2019/6
Y1 - 2019/6
N2 - Background: With the increase of antimicrobial resistance in recent decades, other methods of preventing and fighting infections must be considered. Burn patients, whose wound areas are often extensive, are especially prone to wound infections. The loading of bacterial nanocellulose (BNC) with antiseptics has already been successfully performed but unfortunately, the described procedure is time-consuming and thus not applicable in a clinical emergency setting. Therefore, a clinically feasible approach was established. Material and methods: Sheets of BNC-based wound dressings were placed into antiseptic solutions containing PHMB (Prontosan® and LAVANID® 2) and were left to soak for up to two hours. At different time points, samples were analysed for their concentration of PHMB and antiseptic efficacy. Results: Within 30 min, clinically relevant concentrations of PHMB were achieved in the BNC-based wound dressing. The 30-min PHMB uptake for Prontosan® and LAVANID® 2 resulted in concentrations of 0.05% and 0.019%, respectively. Samples from the PHMB loaded dressing showed a dose dependent antiseptic efficacy for Staphylococcus aureus. Conclusion: This experiment showed that the loading of BNC-based wound dressings with PHMB-containing antiseptics was achieved by a simple and quick procedure. According to studies a PHMB concentration of 0.001% can already inhibits all bacterial growth, indicating that the concentrations of PHMB in the BNC-based wound dressings after 30 min are higher than the minimal inhibitory concentration and the antiseptic efficacy after 120 min loading analysed by an standardized bacterial disk diffusion assay was shown to be comparable to the clinically used Suprasorb® X + PHMB wound dressing.
AB - Background: With the increase of antimicrobial resistance in recent decades, other methods of preventing and fighting infections must be considered. Burn patients, whose wound areas are often extensive, are especially prone to wound infections. The loading of bacterial nanocellulose (BNC) with antiseptics has already been successfully performed but unfortunately, the described procedure is time-consuming and thus not applicable in a clinical emergency setting. Therefore, a clinically feasible approach was established. Material and methods: Sheets of BNC-based wound dressings were placed into antiseptic solutions containing PHMB (Prontosan® and LAVANID® 2) and were left to soak for up to two hours. At different time points, samples were analysed for their concentration of PHMB and antiseptic efficacy. Results: Within 30 min, clinically relevant concentrations of PHMB were achieved in the BNC-based wound dressing. The 30-min PHMB uptake for Prontosan® and LAVANID® 2 resulted in concentrations of 0.05% and 0.019%, respectively. Samples from the PHMB loaded dressing showed a dose dependent antiseptic efficacy for Staphylococcus aureus. Conclusion: This experiment showed that the loading of BNC-based wound dressings with PHMB-containing antiseptics was achieved by a simple and quick procedure. According to studies a PHMB concentration of 0.001% can already inhibits all bacterial growth, indicating that the concentrations of PHMB in the BNC-based wound dressings after 30 min are higher than the minimal inhibitory concentration and the antiseptic efficacy after 120 min loading analysed by an standardized bacterial disk diffusion assay was shown to be comparable to the clinically used Suprasorb® X + PHMB wound dressing.
KW - Antimicrobial wound dressing
KW - Antiseptic uptake
KW - BNC
KW - Burn treatment
KW - PHMB
KW - Staphylococcus aureus
UR - http://www.scopus.com/inward/record.url?scp=85057438107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057438107&partnerID=8YFLogxK
U2 - 10.1016/j.burns.2018.10.023
DO - 10.1016/j.burns.2018.10.023
M3 - Article
C2 - 30509765
AN - SCOPUS:85057438107
SN - 0305-4179
VL - 45
SP - 898
EP - 904
JO - Burns
JF - Burns
IS - 4
ER -